Nuvectis Pharma to present NXP900 data at 2026 cancer research meeting
Go back to Nuvectis Pharma to present NXP900 data at 2026 cancer research meeting| (NASDAQ: NVCT) | Delayed: 19.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.63 | 52 Week High | $ | |||
| Open | $19.63 | 52 Week Low | $ | |||
| Day High | $19.63 | P/E | N/A | |||
| Day Low | $19.63 | EPS | $ | |||
| Volume | 92 | |||||

